Unbound MEDLINE

Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] Journal article

 
TitleProduction and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.
Author(s)Franco EJ, Sonneson GJ, Delegge TJ, Hofstetter H, Horn JR, Hofstetter O 
InstitutionDepartment of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115-2862, USA.
SourceJ Chromatogr B Analyt Technol Biomed Life Sci 2009 Jun 13.
AbstractThis work demonstrates the feasibility of using a camelid single domain antibody for immunoaffinity chromatographic separation of small molecules. An anti-caffeine VHH antibody was produced by grafting the complementarity determining sequences of a previously generated antibody onto an anti-RNase A antibody scaffold, followed by expression in E. coli. Analysis of the binding properties of the antibody by ELISA and fluorescence-based thermal shift assays showed that it recognizes not only caffeine, but also theophylline, theobromine, and paraxanthine, albeit with lower affinity. Further investigation of the effect of environmental conditions, i.e., temperature, pH, and ionic strength, on the antibody using these methods provided useful information about potential elution conditions to be used in chromatographic applications. Immobilization of the VHH onto a high flow-through synthetic support material resulted in a stationary phase capable of separating caffeine and its metabolites.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19560409
  
Advertise on this site.